{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:36:53Z","timestamp":1777383413215,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40123-023-00664-6","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T17:21:12Z","timestamp":1675876872000},"page":"1173-1180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Adjunctive Intravitreal Conbercept Injection at the End of 25G Vitrectomy on Severe Proliferative Diabetic Retinopathy: 6-Month Outcomes of a Randomised Controlled Trial"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"chictr2200060735","registry":"10.18810\/chictr"}],"author":[{"given":"Houshuo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunli","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"2","key":"664_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000328407","volume":"226","author":"D Ozone","year":"2011","unstructured":"Ozone D, et\u00a0al. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Ophthalmologica. 2011;226(2):76\u201380.","journal-title":"Ophthalmologica"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2147\/OPTH.S252285","volume":"14","author":"H Al-Khersan","year":"2020","unstructured":"Al-Khersan H, et\u00a0al. Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol. 2020;14:1559\u201363.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"664_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0161-6420(83)34540-1","volume":"90","author":"AP Schachat","year":"1983","unstructured":"Schachat AP, et\u00a0al. Complications of vitreous surgery for diabetic retinopathy. II Postoperative complications. Ophthalmology. 1983;90(5):522\u201330.","journal-title":"Ophthalmology"},{"issue":"4","key":"664_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2012.11.004","volume":"155","author":"MK Khuthaila","year":"2013","unstructured":"Khuthaila MK, et\u00a0al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155(4):757-763.e1-2.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"664_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.exer.2011.09.002","volume":"97","author":"H Li","year":"2012","unstructured":"Li H, et\u00a0al. Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit. Exp Eye Res. 2012;97(1):154\u20139.","journal-title":"Exp Eye Res"},{"issue":"10","key":"664_CR6","first-page":"914","volume":"35","author":"J Guo","year":"2017","unstructured":"Guo J, et\u00a0al. Clinical effect of vitreoretinal surgery combined with intravitreal injection of conbercept or ranibizumab on severe proliferative diabetic retinopathy. Chin J Exp Ophthalmol. 2017;35(10):914\u20139.","journal-title":"Chin J Exp Ophthalmol"},{"key":"664_CR7","first-page":"2311","volume":"9","author":"X Lu","year":"2015","unstructured":"Lu X, Sun X. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des Dev Ther. 2015;9:2311\u201320.","journal-title":"Drug Des Dev Ther"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","volume":"197","author":"K Liu","year":"2019","unstructured":"Liu K, et\u00a0al. Conbercept for treatment of neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study. Am J Ophthalmol. 2019;197:156\u201367.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"664_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","volume":"36","author":"L Su","year":"2016","unstructured":"Su L, et\u00a0al. Intravitreal conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy. Retina. 2016;36(5):938\u201343.","journal-title":"Retina"},{"issue":"5","key":"664_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/jop.2019.0149","volume":"36","author":"S Gao","year":"2020","unstructured":"Gao S, et\u00a0al. Intravitreal conbercept injection as an adjuvant in vitrectomy with silicone oil infusion for severe proliferative diabetic retinopathy. J Ocul Pharmacol Ther. 2020;36(5):304\u201310.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"664_CR11","first-page":"1217","volume":"11","author":"JB Mao","year":"2018","unstructured":"Mao JB, et\u00a0al. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy. Int J Ophthalmol. 2018;11(7):1217\u201321.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"664_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jebm.12379","volume":"13","author":"R Pranata","year":"2020","unstructured":"Pranata R, Vania A. Intravitreal conbercept improves outcome in patients undergoing vitrectomy for proliferative diabetic retinopathy: a systematic review and meta-analysis. J Evid Based Med. 2020;13(2):116\u201324.","journal-title":"J Evid Based Med"},{"issue":"9","key":"664_CR13","first-page":"865","volume":"17","author":"L Shi","year":"2012","unstructured":"Shi L, Huang YF. Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy. J Res Med Sci. 2012;17(9):865\u201371.","journal-title":"J Res Med Sci"},{"issue":"6","key":"664_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bjo.2005.087403","volume":"90","author":"JI Patel","year":"2006","unstructured":"Patel JI, Hykin PG, Cree IA. Diabetic cataract removal: postoperative progression of maculopathy\u2014growth factor and clinical analysis. Br J Ophthalmol. 2006;90(6):697\u2013701.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"664_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00417-008-0980-7","volume":"247","author":"E Stefansson","year":"2009","unstructured":"Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):147\u201363.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"664_CR16","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41433-019-0396-0","volume":"33","author":"X Ren","year":"2019","unstructured":"Ren X, et\u00a0al. Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy. Eye (Lond). 2019;33(7):1177\u201383.","journal-title":"Eye (Lond)"},{"issue":"10","key":"664_CR17","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0b013e3181d6def0","volume":"30","author":"RA Cheema","year":"2010","unstructured":"Cheema RA, et\u00a0al. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Retina. 2010;30(10):1646\u201350.","journal-title":"Retina"},{"issue":"20","key":"664_CR18","doi-asserted-by":"publisher","first-page":"e15735","DOI":"10.1097\/MD.0000000000015735","volume":"98","author":"X Liang","year":"2019","unstructured":"Liang X, et\u00a0al. Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (observational study). Medicine. 2019;98(20):e15735.","journal-title":"Medicine"},{"issue":"4","key":"664_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","volume":"13","author":"JT Holladay","year":"1997","unstructured":"Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13(4):388\u201391.","journal-title":"J Refract Surg"},{"issue":"2","key":"664_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","volume":"30","author":"JT Holladay","year":"2004","unstructured":"Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30(2):287\u201390.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"664_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0974-9233.106387","volume":"20","author":"T Sato","year":"2013","unstructured":"Sato T, et\u00a0al. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy. Middle East Afr J Ophthalmol. 2013;20(1):51\u20135.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, et\u00a0al. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"664_CR23","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1111\/j.1755-3768.2010.02030.x","volume":"88","author":"MG Petrovi\u010d","year":"2010","unstructured":"Petrovi\u010d MG, et\u00a0al. Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy. Acta Ophthalmol. 2010;88(8):e311\u20136.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"664_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12886-020-01532-8","volume":"20","author":"Y Ding","year":"2020","unstructured":"Ding Y, et\u00a0al. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy. BMC Ophthalmol. 2020;20(1):292.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"664_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/sj.eye.6702213","volume":"21","author":"H Funatsu","year":"2007","unstructured":"Funatsu H, et\u00a0al. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines. Eye (Lond). 2007;21(3):377\u201382.","journal-title":"Eye (Lond)"},{"issue":"5","key":"664_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00417-009-1247-7","volume":"248","author":"DH Park","year":"2010","unstructured":"Park DH, Shin JP, Kim SY. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study. Graefes Arch Clin Exp Ophthalmol. 2010;248(5):641\u201350.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"664_CR27","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","volume":"118","author":"J Ahn","year":"2011","unstructured":"Ahn J, et\u00a0al. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. Ophthalmology. 2011;118(11):2218\u201326.","journal-title":"Ophthalmology"},{"issue":"Suppl 4","key":"664_CR28","first-page":"S136","volume":"95","author":"C Jirawison","year":"2012","unstructured":"Jirawison C, Ittipunkul N. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study. J Med Assoc Thai. 2012;95(Suppl 4):S136\u201342.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"664_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5301\/ejo.5000327","volume":"24","author":"T G\u00f6nc\u00fc","year":"2014","unstructured":"G\u00f6nc\u00fc T, \u00d6zdek S, \u00dcnl\u00fc M. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage. Eur J Ophthalmol. 2014;24(1):88\u201393.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"664_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12886-020-1321-9","volume":"20","author":"T Jiang","year":"2020","unstructured":"Jiang T, et\u00a0al. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study. BMC Ophthalmol. 2020;20(1):43.","journal-title":"BMC Ophthalmol"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.08.013","volume":"183","author":"J Castillo","year":"2017","unstructured":"Castillo J, et\u00a0al. Preoperative bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation. Am J Ophthalmol. 2017;183:1\u201310.","journal-title":"Am J Ophthalmol"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ajo.2019.05.007","volume":"207","author":"JF Arevalo","year":"2019","unstructured":"Arevalo JF, et\u00a0al. Preoperative bevacizumab for tractional retinal detachment in proliferative diabetic retinopathy: a prospective randomized clinical trial. Am J Ophthalmol. 2019;207:279\u201387.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"664_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","volume":"26","author":"M Zhang","year":"2009","unstructured":"Zhang M, et\u00a0al. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization. Pharm Res. 2009;26(1):204\u201310.","journal-title":"Pharm Res"},{"issue":"1","key":"664_CR34","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1038\/s41598-020-60378-8","volume":"10","author":"I Taskintuna","year":"2020","unstructured":"Taskintuna I, et\u00a0al. Comparison of outcomes of four different treatment modalities for diabetic vitreous haemorrhage. Sci Rep. 2020;10(1):3674.","journal-title":"Sci Rep"},{"issue":"3","key":"664_CR35","first-page":"502","volume":"31","author":"L Ficker","year":"1990","unstructured":"Ficker L, et\u00a0al. Cefazolin levels after intravitreal injection. Effects of inflammation and surgery. Investig Ophthalmol Vis Sci. 1990;31(3):502\u20135.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"19","key":"664_CR36","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2019.5790","volume":"321","author":"CW Baker","year":"2019","unstructured":"Baker CW, et\u00a0al. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial. JAMA. 2019;321(19):1880\u201394.","journal-title":"JAMA"},{"issue":"4","key":"664_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamaophthalmol.2019.6035","volume":"138","author":"AR Glassman","year":"2020","unstructured":"Glassman AR, et\u00a0al. Assessment of the DRCR retina network approach to management with initial observation for eyes with center-involved diabetic macular edema and good visual acuity: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2020;138(4):341\u20139.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"664_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/02713683.2019.1703007","volume":"45","author":"S Zafar","year":"2020","unstructured":"Zafar S, et\u00a0al. Real-world outcomes among eyes with center-involving diabetic macular edema and good visual acuity. Curr Eye Res. 2020;45(7):879\u201387.","journal-title":"Curr Eye Res"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00664-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:30:44Z","timestamp":1678685444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00664-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00664-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}